CytoDyn Appoints Lauren Wilcoxen as Chief Operating Officer
CytoDyn (CYDY) has announced the appointment of Lauren Wilcoxen, Ph.D., to the role of Chief Operating Officer and Head of Regulatory Affairs. The appointment is scheduled to take effect on November 20, 2026. Dr. Wilcoxen joins CytoDyn from Xilio Therapeutics, where she most recently served as Senior Vice President of Regulatory Affairs. Her transition into this leadership role is expected to oversee the company's operational and regulatory strategies moving forward.

Tickers: $CYDY
Topics: executive appointment leadership change regulatory affairs
Read the full article at Seeking Alpha
Part of the story CytoDyn Appoints Lauren Wilcoxen as Chief Operating Officer (6 articles)